Ameriprise’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.23M | Buy |
6,551
+135
| +2% | +$26K | ﹤0.01% | 3199 |
|
|
2025
Q4 | $1.21M | Sell |
6,416
-79
| -1% | -$14.6K | ﹤0.01% | 3244 |
|
|
2025
Q3 | $1.08M | Sell |
6,495
-929
| -13% | -$151K | ﹤0.01% | 3325 |
|
|
2025
Q2 | $1.14M | Sell |
7,424
-172
| -2% | -$25.6K | ﹤0.01% | 3210 |
|
|
2025
Q1 | $1.2M | Sell |
7,596
-353
| -4% | -$57.3K | ﹤0.01% | 3135 |
|
|
2024
Q4 | $1.25M | Buy |
7,949
+3,733
| +89% | +$628K | ﹤0.01% | 3147 |
|
|
2024
Q3 | $748K | Sell |
4,216
-95
| -2% | -$16.9K | ﹤0.01% | 3334 |
|
|
2024
Q2 | $726K | Sell |
4,311
-543
| -11% | -$88.8K | ﹤0.01% | 3298 |
|
|
2024
Q1 | $807K | Sell |
4,854
-1,557
| -24% | -$258K | ﹤0.01% | 3257 |
|
|
2023
Q4 | $1.06M | Sell |
6,411
-136
| -2% | -$20.9K | ﹤0.01% | 3166 |
|
|
2023
Q3 | $1.02M | Buy |
6,547
+79
| +1% | +$12.6K | ﹤0.01% | 3138 |
|
|
2023
Q2 | $1.01M | Sell |
6,468
-62
| -0.9% | -$9.9K | ﹤0.01% | 3172 |
|
|
2023
Q1 | $1.06M | Sell |
6,530
-2,133
| -25% | -$345K | ﹤0.01% | 3123 |
|
|
2022
Q4 | $1.38M | Buy |
8,663
+2,463
| +40% | +$390K | ﹤0.01% | 2975 |
|
|
2022
Q3 | $873K | Buy |
6,200
+372
| +6% | +$56.2K | ﹤0.01% | 3180 |
|
|
2022
Q2 | $850K | Sell |
5,828
-367
| -6% | -$54.7K | ﹤0.01% | 3188 |
|
|
2022
Q1 | $1M | Sell |
6,195
-993
| -14% | -$161K | ﹤0.01% | 3217 |
|
|
2021
Q4 | $1.36M | Buy |
7,188
+76
| +1% | +$14.7K | ﹤0.01% | 3113 |
|
|
2021
Q3 | $1.44M | Sell |
7,112
-354
| -5% | -$74.3K | ﹤0.01% | 2997 |
|
|
2021
Q2 | $1.5M | Buy |
7,466
+603
| +9% | +$112K | ﹤0.01% | 3032 |
|
|
2021
Q1 | $1.2M | Buy |
6,863
+240
| +4% | +$43.4K | ﹤0.01% | 3071 |
|
|
2020
Q4 | $1.12M | Buy |
6,623
+41
| +0.6% | +$6.75K | ﹤0.01% | 3040 |
|
|
2020
Q3 | $1.07M | Buy |
6,582
+542
| +9% | +$88.1K | ﹤0.01% | 2943 |
|
|
2020
Q2 | $984K | Buy |
6,040
+4,061
| +205% | +$617K | ﹤0.01% | 2922 |
|
|
2020
Q1 | $253K | Sell |
1,979
-1,584
| -44% | -$213K | ﹤0.01% | 3370 |
|
|
2019
Q4 | $497K | Buy |
3,563
+793
| +29% | +$104K | ﹤0.01% | 3328 |
|
|
2019
Q3 | $327K | Sell |
2,770
-2,926
| -51% | -$364K | ﹤0.01% | 3435 |
|
|
2019
Q2 | $735K | Sell |
5,696
-356
| -6% | -$43.9K | ﹤0.01% | 3185 |
|
|
2019
Q1 | $778K | Sell |
6,052
-653
| -10% | -$82.5K | ﹤0.01% | 3133 |
|
|
2018
Q4 | $742K | Sell |
6,705
-814
| -11% | -$98.3K | ﹤0.01% | 3046 |
|
|
2018
Q3 | $1.02M | Buy |
7,519
+705
| +10% | +$91.7K | ﹤0.01% | 3065 |
|
|
2018
Q2 | $818K | Sell |
6,814
-378
| -5% | -$44.5K | ﹤0.01% | 3086 |
|
|
2018
Q1 | $866K | Sell |
7,192
-421
| -6% | -$52.8K | ﹤0.01% | 3034 |
|
|
2017
Q4 | $947K | Sell |
7,613
-302
| -4% | -$38.6K | ﹤0.01% | 2995 |
|
|
2017
Q3 | $1.06M | Sell |
7,915
-951
| -11% | -$124K | ﹤0.01% | 2936 |
|
|
2017
Q2 | $1.11M | Sell |
8,866
-826
| -9% | -$99.6K | ﹤0.01% | 2896 |
|
|
2017
Q1 | $1.15M | Buy |
9,692
+729
| +8% | +$85.3K | ﹤0.01% | 2831 |
|
|
2016
Q4 | $964K | Buy |
+8,963
| New | +$975K | ﹤0.01% | 2988 |
|
|
2016
Q2 | – | Sell |
-10,365
| Closed | -$1.07M | – | 3777 |
|
|
2016
Q1 | $1.07M | Sell |
10,365
-5,069
| -33% | -$529K | ﹤0.01% | 2813 |
|
|
2015
Q4 | $1.96M | Buy |
15,434
+1,813
| +13% | +$222K | ﹤0.01% | 2614 |
|
|
2015
Q3 | $1.56M | Sell |
13,621
-2,575
| -16% | -$341K | ﹤0.01% | 2760 |
|
|
2015
Q2 | $2.18M | Sell |
16,196
-4,596
| -22% | -$611K | ﹤0.01% | 2700 |
|
|
2015
Q1 | $2.69M | Buy |
20,792
+3,138
| +18% | +$394K | ﹤0.01% | 2440 |
|
|
2014
Q4 | $2.04M | Buy |
17,654
+3,195
| +22% | +$360K | ﹤0.01% | 2556 |
|
|
2014
Q3 | $1.53M | Sell |
14,459
-1,069
| -7% | -$108K | ﹤0.01% | 2614 |
|
|
2014
Q2 | $1.48M | Buy |
15,528
+1,720
| +12% | +$154K | ﹤0.01% | 2638 |
|
|
2014
Q1 | $1.26M | Buy |
13,808
+5,191
| +60% | +$505K | ﹤0.01% | 2640 |
|
|
2013
Q4 | $763K | Buy |
8,617
+340
| +4% | +$28.4K | ﹤0.01% | 2737 |
|
|
2013
Q3 | $685K | Buy |
8,277
+1,130
| +16% | +$88.7K | ﹤0.01% | 2803 |
|
|
2013
Q2 | $490K | Buy |
+7,147
| New | +$497K | ﹤0.01% | 2827 |
|
Other funds holding BBH
MIM
CCA
BFG
Ameriprise's BBH Position: Q1 2026 in Review
Ameriprise increased its VanEck Biotech ETF (BBH) stake by 2.1% in Q1 2026, buying an estimated $26K and bringing the position to 6,551 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #3199.
Ameriprise first reported a position in BBH in Q2 2013 and has held it in 50 quarters since. The position peaked at $2.69M in Q1 2015. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Ameriprise held 6,551 shares of VanEck Biotech ETF worth $1.23M as of Q1 2026.
- Ameriprise bought 135 VanEck Biotech ETF shares in Q1 2026, an estimated $26K.
- VanEck Biotech ETF made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3199 holding.
- Ameriprise first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 50 quarters since.
- Ameriprise's VanEck Biotech ETF position peaked at $2.69M in Q1 2015.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.